Legacy Private Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.31M | Sell |
10,582
-240
| -2% | -$115K | 0.29% | 67 |
|
|
2026
Q1 | $5.32M | Sell |
10,822
-95
| -0.9% | -$51.6K | 0.33% | 63 |
|
|
2025
Q4 | $6.33M | Sell |
10,917
-107
| -1% | -$60.5K | 0.37% | 55 |
|
|
2025
Q3 | $5.35M | Sell |
11,024
-69
| -0.6% | -$32.1K | 0.32% | 65 |
|
|
2025
Q2 | $4.5M | Sell |
11,093
-556
| -5% | -$232K | 0.29% | 69 |
|
|
2025
Q1 | $5.8M | Sell |
11,649
-263
| -2% | -$142K | 0.4% | 51 |
|
|
2024
Q4 | $6.2M | Buy |
11,912
+205
| +2% | +$113K | 0.41% | 53 |
|
|
2024
Q3 | $7.24M | Sell |
11,707
-117
| -1% | -$69.3K | 0.49% | 47 |
|
|
2024
Q2 | $6.54M | Sell |
11,824
-99
| -0.8% | -$56.7K | 0.46% | 52 |
|
|
2024
Q1 | $6.93M | Sell |
11,923
-118
| -1% | -$66.2K | 0.51% | 46 |
|
|
2023
Q4 | $6.39M | Buy |
12,041
+58
| +0.5% | +$28.1K | 0.51% | 51 |
|
|
2023
Q3 | $6.07M | Sell |
11,983
-5
| -0% | -$2.66K | 0.52% | 47 |
|
|
2023
Q2 | $6.25M | Sell |
11,988
-875
| -7% | -$472K | 0.52% | 51 |
|
|
2023
Q1 | $7.41M | Buy |
12,863
+92
| +0.7% | +$51.9K | 0.63% | 36 |
|
|
2022
Q4 | $7.03M | Sell |
12,771
-724
| -5% | -$384K | 0.64% | 43 |
|
|
2022
Q3 | $6.84M | Buy |
13,495
+351
| +3% | +$196K | 0.65% | 37 |
|
|
2022
Q2 | $7.14M | Sell |
13,144
-33
| -0.3% | -$18.2K | 0.64% | 42 |
|
|
2022
Q1 | $7.78M | Sell |
13,177
-877
| -6% | -$504K | 0.6% | 38 |
|
|
2021
Q4 | $9.38M | Buy |
14,054
+488
| +4% | +$305K | 0.7% | 33 |
|
|
2021
Q3 | $7.75M | Buy |
13,566
+303
| +2% | +$166K | 0.63% | 40 |
|
|
2021
Q2 | $6.69M | Sell |
13,263
-124
| -0.9% | -$58.5K | 0.56% | 47 |
|
|
2021
Q1 | $6.11M | Sell |
13,387
-824
| -6% | -$393K | 0.55% | 52 |
|
|
2020
Q4 | $6.62M | Sell |
14,211
-1,749
| -11% | -$820K | 0.63% | 44 |
|
|
2020
Q3 | $7.05M | Sell |
15,960
-644
| -4% | -$266K | 0.73% | 38 |
|
|
2020
Q2 | $6.02M | Sell |
16,604
-618
| -4% | -$207K | 0.66% | 43 |
|
|
2020
Q1 | $4.88M | Sell |
17,222
-1,087
| -6% | -$343K | 0.63% | 45 |
|
|
2019
Q4 | $5.95M | Sell |
18,309
-704
| -4% | -$213K | 0.62% | 46 |
|
|
2019
Q3 | $5.54M | Sell |
19,013
-82
| -0.4% | -$23.5K | 0.62% | 49 |
|
|
2019
Q2 | $5.61M | Buy |
19,095
+659
| +4% | +$182K | 0.64% | 48 |
|
|
2019
Q1 | $5.05M | Buy |
18,436
+1,441
| +8% | +$359K | 0.6% | 54 |
|
|
2018
Q4 | $3.8M | Buy |
16,995
+360
| +2% | +$84.5K | 0.49% | 58 |
|
|
2018
Q3 | $4.06M | Buy |
16,635
+635
| +4% | +$146K | 0.46% | 56 |
|
|
2018
Q2 | $3.31M | Buy |
16,000
+3,690
| +30% | +$783K | 0.4% | 61 |
|
|
2018
Q1 | $2.54M | Sell |
12,310
-1,103
| -8% | -$232K | 0.3% | 79 |
|
|
2017
Q4 | $2.55M | Buy |
13,413
+5,034
| +60% | +$964K | 0.3% | 79 |
|
|
2017
Q3 | $1.58M | Sell |
8,379
-3,101
| -27% | -$562K | 0.19% | 101 |
|
|
2017
Q2 | $2M | Sell |
11,480
-17,628
| -61% | -$2.96M | 0.25% | 89 |
|
|
2017
Q1 | $4.47M | Buy |
29,108
+567
| +2% | +$86.7K | 0.57% | 51 |
|
|
2016
Q4 | $4.03M | Buy |
28,541
+15,341
| +116% | +$2.26M | 0.55% | 52 |
|
|
2016
Q3 | $2.1M | Sell |
13,200
-288
| -2% | -$44.4K | 0.29% | 96 |
|
|
2016
Q2 | $1.99M | Buy |
13,488
+6,345
| +89% | +$936K | 0.29% | 96 |
|
|
2016
Q1 | $1.01M | Buy |
7,143
+1,563
| +28% | +$209K | 0.15% | 132 |
|
|
2015
Q4 | $792K | Buy |
5,580
+3,890
| +230% | +$519K | 0.12% | 147 |
|
|
2015
Q3 | $207K | Buy |
+1,690
| New | +$220K | 0.03% | 229 |
|
|
2015
Q1 | – | Sell |
-2,515
| Closed | -$315K | – | 259 |
|
|
2014
Q4 | $315K | Sell |
2,515
-907
| -27% | -$110K | 0.05% | 215 |
|
|
2014
Q3 | $416K | Sell |
3,422
-720
| -17% | -$87.5K | 0.06% | 192 |
|
|
2014
Q2 | $489K | Sell |
4,142
-68
| -2% | -$8K | 0.08% | 183 |
|
|
2014
Q1 | $506K | Sell |
4,210
-2,833
| -40% | -$337K | 0.09% | 144 |
|
|
2013
Q4 | $784K | Buy |
7,043
+828
| +13% | +$82.3K | 0.14% | 117 |
|
|
2013
Q3 | $573K | Buy |
6,215
+460
| +8% | +$41.6K | 0.12% | 117 |
|
|
2013
Q2 | $487K | Buy |
+5,755
| New | +$479K | 0.11% | 120 |
|
Other funds holding TMO
Legacy Private Trust's TMO Position: Q2 2026 in Review
Legacy Private Trust reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q2 2026, selling an estimated $115K and leaving 10,582 shares worth $5.31M. The position accounts for 0.29% of the portfolio, ranked #67.
Legacy Private Trust first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.38M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Legacy Private Trust held 10,582 shares of Thermo Fisher Scientific worth $5.31M as of Q2 2026.
- Legacy Private Trust sold 240 Thermo Fisher Scientific shares in Q2 2026, an estimated $115K.
- Thermo Fisher Scientific made up 0.29% of Legacy Private Trust's portfolio in Q2 2026, its #67 holding.
- Legacy Private Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
- Legacy Private Trust's Thermo Fisher Scientific position peaked at $9.38M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Legacy Private Trust's 13F filing for Q2 2026, filed 21 Jul 2026.